279 related articles for article (PubMed ID: 7905093)
1. Changes in prostate cancer incidence and treatment in USA.
Lu-Yao GL; Greenberg ER
Lancet; 1994 Jan; 343(8892):251-4. PubMed ID: 7905093
[TBL] [Abstract][Full Text] [Related]
2. Screening, treatment, and prostate cancer mortality in the Seattle area and Connecticut: fifteen-year follow-up.
Lu-Yao G; Albertsen PC; Stanford JL; Stukel TA; Walker-Corkery E; Barry MJ
J Gen Intern Med; 2008 Nov; 23(11):1809-14. PubMed ID: 18795372
[TBL] [Abstract][Full Text] [Related]
3. Increasing use of radical prostatectomy for locally advanced prostate cancer in the USA and Germany: a comparative population-based study.
Hager B; Kraywinkel K; Keck B; Katalinic A; Meyer M; Zeissig SR; Scheufele R; Wirth MP; Huber J
Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):61-66. PubMed ID: 27618951
[TBL] [Abstract][Full Text] [Related]
4. Prostate carcinoma incidence and patient mortality: the effects of screening and early detection.
Brawley OW
Cancer; 1997 Nov; 80(9):1857-63. PubMed ID: 9351560
[TBL] [Abstract][Full Text] [Related]
5. Rise and fall of radical prostatectomy rates from 1989 to 1996.
Sheikh K; Bullock C
Urology; 2002 Mar; 59(3):378-82. PubMed ID: 11880074
[TBL] [Abstract][Full Text] [Related]
6. The role of increasing detection in the rising incidence of prostate cancer.
Potosky AL; Miller BA; Albertsen PC; Kramer BS
JAMA; 1995 Feb; 273(7):548-52. PubMed ID: 7530782
[TBL] [Abstract][Full Text] [Related]
7. Patterns of prostate cancer treatment by clinical stage and age.
Meltzer D; Egleston B; Abdalla I
Am J Public Health; 2001 Jan; 91(1):126-8. PubMed ID: 11189804
[TBL] [Abstract][Full Text] [Related]
8. Understanding variation in primary prostate cancer treatment within the Veterans Health Administration.
Nambudiri VE; Landrum MB; Lamont EB; McNeil BJ; Bozeman SR; Freedland SJ; Keating NL
Urology; 2012 Mar; 79(3):537-45. PubMed ID: 22245306
[TBL] [Abstract][Full Text] [Related]
9. The results of prostate carcinoma screening in the U.S. as reflected in the surveillance, epidemiology, and end results program.
Smart CR
Cancer; 1997 Nov; 80(9):1835-44. PubMed ID: 9351557
[TBL] [Abstract][Full Text] [Related]
10. Trends in the use of radical prostatectomy for treatment of prostate cancer.
Ellison LM; Heaney JA; Birkmeyer JD
Eff Clin Pract; 1999; 2(5):228-33. PubMed ID: 10623055
[TBL] [Abstract][Full Text] [Related]
11. Trends and black/white differences in treatment for nonmetastatic prostate cancer.
Klabunde CN; Potosky AL; Harlan LC; Kramer BS
Med Care; 1998 Sep; 36(9):1337-48. PubMed ID: 9749657
[TBL] [Abstract][Full Text] [Related]
12. Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate.
Harlan L; Brawley O; Pommerenke F; Wali P; Kramer B
J Clin Oncol; 1995 Jan; 13(1):93-100. PubMed ID: 7799048
[TBL] [Abstract][Full Text] [Related]
13. Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut.
Lu-Yao G; Albertsen PC; Stanford JL; Stukel TA; Walker-Corkery ES; Barry MJ
BMJ; 2002 Oct; 325(7367):740. PubMed ID: 12364300
[TBL] [Abstract][Full Text] [Related]
14. Incidence of initial local therapy among men with lower-risk prostate cancer in the United States.
Miller DC; Gruber SB; Hollenbeck BK; Montie JE; Wei JT
J Natl Cancer Inst; 2006 Aug; 98(16):1134-41. PubMed ID: 16912266
[TBL] [Abstract][Full Text] [Related]
15. Comparison of prostate cancer survival in Germany and the USA: can differences be attributed to differences in stage distributions?
Winter A; Sirri E; Jansen L; Wawroschek F; Kieschke J; Castro FA; Krilaviciute A; Holleczek B; Emrich K; Waldmann A; Brenner H;
BJU Int; 2017 Apr; 119(4):550-559. PubMed ID: 27208546
[TBL] [Abstract][Full Text] [Related]
16. Physician visits prior to treatment for clinically localized prostate cancer.
Jang TL; Bekelman JE; Liu Y; Bach PB; Basch EM; Elkin EB; Zelefsky MJ; Scardino PT; Begg CB; Schrag D
Arch Intern Med; 2010 Mar; 170(5):440-50. PubMed ID: 20212180
[TBL] [Abstract][Full Text] [Related]
17. Locally advanced prostate cancer: a population-based study of treatment patterns.
Lowrance WT; Elkin EB; Yee DS; Feifer A; Ehdaie B; Jacks LM; Atoria CL; Zelefsky MJ; Scher HI; Scardino PT; Eastham JA
BJU Int; 2012 May; 109(9):1309-14. PubMed ID: 22085255
[TBL] [Abstract][Full Text] [Related]
18. Increasing Rate of Noninterventional Treatment Management in Localized Prostate Cancer Candidates for Active Surveillance: A North American Population-Based Study.
Bandini M; Nazzani S; Marchioni M; Preisser F; Tian Z; Moschini M; Abdollah F; Suardi N; Graefen M; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
Clin Genitourin Cancer; 2019 Feb; 17(1):72-78.e4. PubMed ID: 30342845
[TBL] [Abstract][Full Text] [Related]
19. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
Nieder AM; Porter MP; Soloway MS
J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
[TBL] [Abstract][Full Text] [Related]
20. Trends in incidence and 5-year mortality in men with newly diagnosed, metastatic prostate cancer-A population-based analysis of 2 national cohorts.
Helgstrand JT; Røder MA; Klemann N; Toft BG; Lichtensztajn DY; Brooks JD; Brasso K; Vainer B; Iversen P
Cancer; 2018 Jul; 124(14):2931-2938. PubMed ID: 29723398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
